HeartCore Q2 Revenue Up 72% but Net Loss Widens to $2M; Cash Drops to $587K
HTCR sits 34% above its 52-week low of $2.01 on light trading volume (0.2× avg).
Summary
HeartCore reported Q2 revenue up 71.6% to $321K but swung to a $2.0M net loss; cash dropped to $587K, though Nasdaq compliance was regained.
Key Events · Earnings and Guidance · HTCR
-
Q2 Revenue Up 72%
Revenue rose to $321,000 from $187,000 a year ago, driven by software development services from HeartCore Luvina.
-
Net Loss Swings to $2.0M
Q2 net loss was $2.0 million versus net income of $1.1 million in Q2 2025, due to higher gross loss, other expenses, and discontinued operations.
-
Cash Drops to $587K
Cash and cash equivalents fell to $587,074 as of June 30, 2026, from $1.9 million at year-end 2025.
-
Nasdaq Compliance Regained
The company regained compliance with the $1.00 minimum bid price requirement, removing a delisting risk.
Analysis · HTCR · Technology
HeartCore's Q2 results show a sharp revenue increase driven by software development, but the company swung to a $2.0 million net loss from a $1.1 million profit a year ago. Cash fell to $587,000 from $1.9 million at year-end, intensifying liquidity concerns already flagged by a going concern warning in May. The regained Nasdaq compliance removes a delisting overhang, but the shrinking cash position and continued losses keep the financial risk elevated.
At the time of this filing, HTCR was trading at $2.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $2.01 to $33.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.